RecruitingNCT06209853

Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient

Correlation Between Prostate-Specific Antigen (PSA) Levels and Fluorine-18 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography (F-18 PSMA PET/CT) Scan Findings in Patients With Prostate Cancer

Sponsor

Assiut University

Enrollment

59 participants

Start Date

Jan 20, 2024

Study Type

OBSERVATIONAL

Conditions

Prostatic Neoplasms

Summary

It is a cross sectional study aimed to correlate between PSA Levels and F-18 PSMA PET/CT Scan findings and to evaluate the impact of PET/CT findings on the patient management

Eligibility

Sex: MALE

Plain Language Summary

Simplified for easier understanding

This study explores the relationship between PSA blood levels (a prostate cancer marker) and the results of a specialized PET/CT scan using a tracer called F-18 PSMA, which lights up prostate cancer cells. Understanding this link could help doctors better interpret scan results in different clinical situations. **You may be eligible if...** - You are a man with a confirmed prostate cancer diagnosis - Your doctor has referred you for an F-18 PSMA PET/CT scan for any clinical reason **You may NOT be eligible if...** - Your prostate cancer is undifferentiated (a rare, aggressive type that doesn't produce PSA) - You are severely ill or cannot remain still during the scan - There are significant motion artifacts in your imaging Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.